Target Audience

This activity is specifically designed for:

  • Key Stakeholders

  • Country Program Managers

  • Decision Makers

  • Implementing Partners

Learning Objectives

At the end of the course, learners should be able to:

  • Share the most recent global guidance related to TB LAM testing

  • Describe the status of TB and TB LAM testing in the Asia Pacific Region

  • Identify current barriers and gaps related to TB LAM testing

  • Propose and facilitate for implementation of TB LAM testing


Actual progress in uptake of TB LF LAM testing has been slow. In 2018, an MSF Access Campaign press release announced that, while 30 countries had procured TB LF LAM tests, only 3 had scaled-up nationally. Reported implementation barriers have included decreased support for CD4 testing, whether the ‘ownership’ of TB LAM testing is by the HIV or TB programs, and insufficient training and implementation guidance. To help address these barriers, this activity addresses the following:

  • WHO TB LAM guidelines

  • From guidelines to reality of TB LAM in the Indian health system

  • TB LAM: A community perspective from Asia

  • DSD in Thailand: Opportunities for integration of TB LAM testing

  • TB LAM implementation considerations

  • Panel discussion: Addressing uptake barriers to TB LF LAM in the APAC region and discussing the way forward

Course Directors

Teri Roberts, Chief of Innovations and Access, The Global Health Impact Group

Patricia Hall, Lead, TB and Clinical Monitoring Team, International Laboratory Branch, Division of Global HIV and TB Center for Global Health, CDC


  • Lucica Ditiu, Executive Director, Stop TB Partnership

  • Nazir Ahmed Ismail, Team Lead, WHO Global TB Programme

  • Leena Menghan, Regional Head, South Asia, MSF Access Campaign

  • Meirinda Sebayang, Chair, JIP (Jaringan Indonesia Positif)

  • Reshmie Ramautarsing, Technical Director, Institute of HIV Research and Innovation (IHRI) in Bangkok

  • N. Kumarasamy, Chief & Director, VHS Infectious Diseases Medical Centre, Director, Chennai Antiviral Research and Treatment (CART) Clinical Research Site, India

Learn more!

Add your email to the mailing list to get the latest updates.